India’s drug regulator warns on Abbott’s bioresorbable stentsPost published:August 9, 2017Post category:Industry NewsThe Drug Controller General of India’s (DCGI) warning pertains to bioresorbable stents used in blood vessels that are 2.5mm or narrower Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostDilip Shanghvi’s oil firm may buy GSPC’s Hazira field Next PostBoeing eyes India tie-ups for drones, digital technology You Might Also Like H2W Technologies introduces TWR-015-346-2RC voice coil actuator June 26, 2018 Vodafone CEO Vittorio Colao: Regulation shouldn’t suit a new entrant’s ambitions August 28, 2017 Infrared Innovation: Developing an Affordable & Portable MWIR Infrared Imaging Solution February 1, 2019
Infrared Innovation: Developing an Affordable & Portable MWIR Infrared Imaging Solution February 1, 2019